Catalyst Wire Dossier Catalyst Wire Dossier

ZYNRELEF

BUPIVACAINE AND MELOXICAM · Heron Therapeutics, Inc.
Drug timelines are a Plus or Pro feature.

20 regulatory and trial events tracked for ZYNRELEF, covering 2021-05-12 to 2026-02-27. Get the full timeline:

Most recent: Clinical Trial Update: Post-Operative Pain Relief: Zynrelef or Periarticular Injections in RATKA [Phase 4]

See pricing